SCHEMBL17899478

SCHEMBL17899478

CC(C)N1CCC(=O)/C(=C/c2cccnc2)C1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 7/20 0.72
RAB9A P51151 7/20 0.72
ALDH1A1 P00352 7/20 0.72
LMNA P02545 5/20 0.72
MITF O75030 3/20 0.72
MAPT P10636 10/20 0.54
HTT P42858 6/20 0.54
KMT2A Q03164 4/20 0.54
MEN1 O00255 3/20 0.54
ATM Q13315 2/20 0.51
MAPK1 P28482 3/20 0.48
NPC1 O15118 1/20 0.48
NSD2 O96028 1/20 0.48
TP53 P04637 1/20 0.45
CYP19A1 P11511 5/20 0.45
HSP90AA1 P07900 1/20 0.45
MIF P14174 1/20 0.45
PKM P14618 1/20 0.45
KDM4E B2RXH2 2/20 0.45
THRB P10828 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17899495 0.84 SMN1; SMN2 (1.00) SMN1; SMN2RAB9AALDH1A1LMNAMITF
SCHEMBL17899480 0.75 SMN1; SMN2 (0.80) SMN1; SMN2RAB9AALDH1A1LMNAMITF
SCHEMBL3731025 0.74 MAPT (0.50) SMN1; SMN2RAB9AALDH1A1LMNAMITF
SCHEMBL3731030 0.74 MAPT (0.50) SMN1; SMN2RAB9AALDH1A1LMNAMITF
SCHEMBL3731028 0.74 MAPT (0.50) SMN1; SMN2RAB9AALDH1A1LMNAMITF
SCHEMBL624720 0.73 MAPT (0.73) SMN1; SMN2RAB9AALDH1A1LMNAMITF
SCHEMBL5594253 0.73 MAPT (0.73) SMN1; SMN2RAB9AALDH1A1LMNAMITF
SCHEMBL625565 0.73 MAPT (0.79) SMN1; SMN2RAB9AALDH1A1LMNAMITF
SCHEMBL5593668 0.73 MAPT (0.73) SMN1; SMN2RAB9AALDH1A1LMNAMITF
SCHEMBL17899482 0.71 MAPT (0.60) SMN1; SMN2RAB9AALDH1A1LMNAMITF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11312676-B2 Small molecule stimulators of steroid receptor coactivator proteins and their use in the treatment of cancer BAYLOR COLLEGE OF MEDICINE (US) 2022-04-26 US disclosed
WO-2016109470-A1 SMALL MOLECULE STIMULATORS OF STEROID RECEPTOR COACTIVATOR PROTEINS AND THEIR USE IN THE TREATMENT OF CANCER BAYLOR COLLEGE OF MEDICINE (US) 2016-07-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11312676-B2 Small molecule stimulators of steroid receptor coactivator proteins and their use in the treatment of cancer NCOA2, NCOA1, NCOA3 SMN1; SMN2 4722/4885RAB9A 3983/4885ALDH1A1 4727/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.